Allogene Therapeutics, Inc.
ALLO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737287
In the last 90 days, Allogene Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 209 institutions reported holding it in 13F filings for Q2 2026, worth $652.0M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Allogene Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 170
- +14 vs. Q2 2025
- Shares held
- 162.1M
- −21.5M (−11.7%) vs. Q2 2025
- Total value
- $201.0M
- −$6.83M (−3.3%) vs. Q2 2025
- New holders
- 30
- 61 more added
- Sold out
- 16
- 37 more reduced
2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALLO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 209 | $652.0M |
| Q1 2026 | 209 | $444.7M |
| Q4 2025 | 172 | $222.7M |
| Q3 2025 | 170 | $201.0M |
| Q2 2025 | 158 | $207.9M |
| Q1 2025 | 171 | $288.5M |
| Q4 2024 | 174 | $401.9M |
| Q3 2024 | 156 | $460.4M |
| Q2 2024 | 175 | $385.1M |
| Q1 2024 | 161 | $586.0M |
| Q4 2023 | 170 | $392.4M |
| Q3 2023 | 155 | $413.3M |
| Q2 2023 | 171 | $662.9M |
| Q1 2023 | 176 | $582.3M |
| Q4 2022 | 168 | $700.9M |
| Q3 2022 | 192 | $1.15B |
| Q2 2022 | 161 | $1.15B |
| Q1 2022 | 180 | $836.7M |
| Q4 2021 | 177 | $1.28B |
| Q3 2021 | 169 | $2.26B |
| Q2 2021 | 182 | $2.25B |
| Q1 2021 | 169 | $3.12B |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Allogene Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HSBC Holdings PLC | 94,065 | $113.8K | 0.00% | −4,426−4.5% | Reduced |
| Nwi Management LP | 100,000 | $124.0K | 0.01% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 102,771 | $127.4K | 0.00% | +102,771 | New |
| HRT Financial LP | 132,531 | $164.0K | 0.00% | +132,531 | New |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 138,900 | $172.2K | 0.00% | 00.0% | Unchanged |
| Headlands Technologies LLC | 139,961 | $173.6K | 0.01% | +139,961 | New |
| Deutsche Bank AG | 140,781 | $174.6K | 0.00% | +61,579+77.7% | Added |
| Wells Fargo & Company | 144,861 | $179.6K | 0.00% | +17,310+13.6% | Added |
| Macquarie Group Ltd | 146,779 | $182.0K | 0.00% | 00.0% | Unchanged |
| Partners Capital Investment Group, LLP | 161,597 | $200.4K | 0.01% | 00.0% | Unchanged |
| Mirae Asset Global ETFs Holdings Ltd. | 164,780 | $204.3K | 0.00% | −14,796−8.2% | Reduced |
| LPL Financial LLC | 177,500 | $220.1K | 0.00% | +3,537+2.0% | Added |
| Gsa Capital Partners LLP | 182,879 | $227.0K | 0.02% | −309,242−62.8% | Reduced |
| Graham Capital Management, L.P. | 197,308 | $244.7K | 0.01% | −104,962−34.7% | Reduced |
| Rhumbline Advisers | 210,726 | $261.3K | 0.00% | +1,390+0.7% | Added |
| Quadrature Capital Ltd | 237,937 | $293.9K | 0.00% | +193,887+440.2% | Added |
| Bridgeway Capital Management, LLC | 250,000 | $310.0K | 0.01% | +250,000 | New |
| Squarepoint Ops LLC | 268,044 | $332.4K | 0.00% | +249,978+1,383.7% | Added |
| Nuveen, LLC | 272,007 | $337.3K | 0.00% | 00.0% | Unchanged |
| Man Group plc | 282,052 | $349.7K | 0.00% | +7,368+2.7% | Added |
| Harold Davidson & Associates Inc. | 295,432 | $366.3K | 0.17% | +160,204+118.5% | Added |
| Alliancebernstein L.P. | 296,498 | $367.7K | 0.00% | 00.0% | Unchanged |
| Ieq Capital, LLC | 376,058 | $466.3K | 0.00% | +189,880+102.0% | Added |
| Bank of New York Mellon Corp | 401,871 | $498.3K | 0.00% | +26,834+7.2% | Added |
| TD Asset Management Inc | 414,074 | $513.5K | 0.00% | −131,314−24.1% | Reduced |
| Raiffeisen Bank International AG | 450,000 | $571.5K | 0.01% | +48,000+11.9% | Added |
| D. E. Shaw & Co., Inc. | 463,898 | $575.2K | 0.00% | +463,898 | New |
| Cerity Partners LLC | 466,732 | $578.7K | 0.00% | +66,465+16.6% | Added |
| Manufacturers Life Insurance Company, The | 489,977 | $607.6K | 0.00% | −4,523−0.9% | Reduced |
| Moloney Securities Asset Management, LLC | 514,000 | $637.4K | 0.08% | +246,500+92.1% | Added |
| Invesco Ltd. | 525,313 | $651.4K | 0.00% | +128,801+32.5% | Added |
| Zacks Investment Management | 526,132 | $652.4K | 0.01% | +13,831+2.7% | Added |
| Acadian Asset Management LLC | 533,809 | $659.0K | 0.00% | +463,343+657.5% | Added |
| Lynx1 Capital Management LP | 546,119 | $677.2K | 0.14% | −10,510,890−95.1% | Reduced |
| Citigroup Inc | 594,099 | $736.7K | 0.00% | −48,443−7.5% | Reduced |
| Barclays PLC | 598,997 | $742.8K | 0.00% | −46,328−7.2% | Reduced |
| FMR LLC | 710,960 | $881.6K | 0.00% | −272,041−27.7% | Reduced |
| XTX Topco Ltd | 774,203 | $960.0K | 0.05% | +746,431+2,687.7% | Added |
| BNP Paribas Arbitrage, SA | 894,314 | $1.11M | 0.00% | +15,327+1.7% | Added |
| JPMorgan Chase & Co | 908,725 | $1.13M | 0.00% | −25,298−2.7% | Reduced |
| Bank of America Corp | 974,320 | $1.21M | 0.00% | −13,175−1.3% | Reduced |
| Royal Bank of Canada | 1,098,569 | $1.36M | 0.00% | +112,269+11.4% | Added |
| Charles Schwab Investment Management Inc | 1,165,280 | $1.44M | 0.00% | −67,255−5.5% | Reduced |
| Goldman Sachs Group Inc | 1,203,708 | $1.49M | 0.00% | −4,299,433−78.1% | Reduced |
| Jane Street Group, LLC | 1,215,773 | $1.51M | 0.00% | +803,143+194.6% | Added |
| Northern Trust Corp | 1,279,628 | $1.59M | 0.00% | +5,336+0.4% | Added |
| Morgan Stanley | 1,299,166 | $1.61M | 0.00% | +690,197+113.3% | Added |
| DAFNA Capital Management LLC | 1,380,118 | $1.71M | 0.42% | 00.0% | Unchanged |
| Standard Life Aberdeen plc | 1,582,265 | $1.96M | 0.00% | +715,015+82.4% | Added |
| Vida Ventures Advisors, LLC | 1,798,163 | $2.23M | 7.59% | 00.0% | Unchanged |
| AQR Capital Management LLC | 1,853,554 | $2.30M | 0.00% | +1,772,930+2,199.0% | Added |
| Dimensional Fund Advisors LP | 2,090,753 | $2.59M | 0.00% | −645,666−23.6% | Reduced |
| State Street Corp | 2,755,378 | $3.42M | 0.00% | +32,636+1.2% | Added |
| Two Sigma Advisers, LP | 2,781,600 | $3.45M | 0.01% | +1,014,200+57.4% | Added |
| Renaissance Technologies LLC | 2,893,812 | $3.59M | 0.00% | +1,223,800+73.3% | Added |
| Wildcat Capital Management, LLC | 2,920,787 | $3.62M | 2.50% | 00.0% | Unchanged |
| Patient Square Capital LP | 2,981,396 | $3.70M | 0.99% | +346,396+13.1% | Added |
| Two Sigma Investments, LP | 3,383,644 | $4.20M | 0.01% | +1,770,419+109.7% | Added |
| Millennium Management LLC | 3,390,026 | $4.20M | 0.00% | +1,887,302+125.6% | Added |
| UBS Group AG | 3,571,157 | $4.43M | 0.00% | +1,532,238+75.1% | Added |
| Price T Rowe Associates Inc | 3,677,474 | $4.56M | 0.00% | −353,398−8.8% | Reduced |
| Geode Capital Management, LLC | 3,833,885 | $4.75M | 0.00% | +39,058+1.0% | Added |
| Frazier Life Sciences Management, L.P. | 3,868,750 | $4.80M | 0.14% | 00.0% | Unchanged |
| Woodline Partners LP | 4,360,608 | $5.41M | 0.03% | 00.0% | Unchanged |
| Primecap Management Co | 7,079,308 | $8.78M | 0.01% | +1,360,168+23.8% | Added |
| Vanguard Group Inc | 9,020,770 | $11.2M | 0.00% | +761,642+9.2% | Added |
| Citadel Advisors LLC | 13,971,557 | $17.3M | 0.01% | +3,718,951+36.3% | Added |
| BlackRock, Inc. | 17,514,674 | $21.7M | 0.00% | −382,726−2.1% | Reduced |
| TPG GP A, LLC | 18,716,306 | $23.2M | 1.26% | 00.0% | Unchanged |
| Pfizer Inc | 22,032,040 | $27.3M | 6.25% | 00.0% | Unchanged |
| Capital World Investors | 0 | $0 | 0.00% | −11,150,000−100.0% | Sold out |
| Darwin Global Management, Ltd. | 0 | $0 | 0.00% | −10,479,791−100.0% | Sold out |
| Foresite Capital Management VI LLC | 0 | $0 | 0.00% | −2,875,357−100.0% | Sold out |
| Gilead Sciences, Inc. | 0 | $0 | 0.00% | −1,156,689−100.0% | Sold out |
| Bourgeon Capital Management LLC | 0 | $0 | 0.00% | −110,000−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −81,843−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −24,544−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −15,077−100.0% | Sold out |
| Rialto Wealth Management, LLC | 0 | $0 | 0.00% | −912−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −747−100.0% | Sold out |
| REAP Financial Group, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −184−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −85−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| Ball & Co Wealth Management Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| CIBC World Markets Corp | – | – | – | – | Not filed |
| EP Wealth Advisors, LLC | – | – | – | – | Not filed |